Conditions: Opiate Dependence
Keywords: opioid dependence VIVITROL opioid-related disorders
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 38
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the safety and tolerability of Medisorb® naltrexone (VIVITROL®) when administered over a period of 24 months to health care professionals who have a history of opioid dependence.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Medisorb naltrexone 380 mg
Intervention descriptions: intervention 1: Intramuscular (IM) injection administered once every 4 weeks for up to 2 years

Protocol document: